BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Daiichi Sankyo
Federal Trade Commission

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,876,872

« Back to Dashboard

Summary for Patent: 6,876,872

Title: Power control apparatus of a foldable portable mobile terminal
Abstract:A power control apparatus in a foldable portable radio terminal which includes a main body, a sub-body, a key-pad including a power key on the main body, an external function key which can be key-input by a user even if the sub-body is shut on the main body is disclosed. The power control apparatus includes a first switch, a second switch, and a control unit for controlling the first and second switch according to powered-on/off state of the terminal. One end of each of the first and second switch is connected in common at a first node connected to the external function key and the other end of the first switch is connected to a first input end of the control unit, and the other end of the second switch and the power key are connected in common via a second node connected to a second input end of the control unit. According to the invention, the external function key (the automatic folder switch for example) as the power key is realized so that the user can power-on the terminal without opening the sub-body even in the powered-off state of the terminal, and the terminal keys can perform their own functions in the powered-off state of the terminal.
Inventor(s): Ko; Moon Jung (Suwon-shi, KR)
Assignee: Samsung Electronics Co., Ltd. (KR)
Application Number:09/841,990
Patent Claim Types:
see list of patent claims

No matches for this query

Foreign Priority and PCT Information for Patent: 6,876,872

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
South Korea2000-64192Oct 31, 2000

International Patent Family for Patent: 6,876,872

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
South Korea20020033938► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus